Substituted quinoline compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S156000

Reexamination Certificate

active

07468378

ABSTRACT:
This invention relates to MTP/Apo-B secretion inhibitors of Formula (I)wherein R1—R7, X1, m and n are as defined in the specification, as well as pharmaceutical compositions comprising the compounds, and methods of use of the compounds and compositions. The compounds of the invention are useful in treating obesity and associated diseases, conditions or disorders.

REFERENCES:
patent: 5712279 (1998-01-01), Biller et al.
patent: 5804588 (1998-09-01), Dyke et al.
patent: 5919795 (1999-07-01), Chang et al.
patent: 5968950 (1999-10-01), Quallich et al.
patent: 6066653 (2000-05-01), Gregg et al.
patent: 6093732 (2000-07-01), Tucker et al.
patent: 6121282 (2000-09-01), Dominianni et al.
patent: 6369075 (2002-04-01), Ruggeri et al.
patent: 6492365 (2002-12-01), Wetterau et al.
patent: 2002/0032238 (2002-03-01), Priepke et al.
patent: 2002/0042516 (2002-04-01), Tom et al.
patent: 2003/0162788 (2003-08-01), Thomas et al.
patent: 2006/0223851 (2006-10-01), Bertinato et al.
patent: 2007/0093525 (2007-04-01), Bertinato et al.
patent: 0059983 (1986-06-01), None
patent: 0643057 (1994-09-01), None
patent: 1099438 (2001-05-01), None
patent: 1099701 (2001-05-01), None
patent: 0584446 (2002-06-01), None
patent: 1447402 (2004-08-01), None
patent: WO95/32948 (1995-12-01), None
patent: WO96/040640 (1996-12-01), None
patent: WO9640640 (1996-12-01), None
patent: WO9743257 (1997-11-01), None
patent: WO9827979 (1998-07-01), None
patent: WO99/14196 (1999-03-01), None
patent: WO0005201 (2000-02-01), None
patent: WO0228835 (2002-04-01), None
patent: WO03002533 (2003-01-01), None
patent: WO03035624 (2003-05-01), None
patent: WO03072532 (2003-09-01), None
patent: WO2004056775 (2004-07-01), None
US5804588 equivalent to RU98123074.
US6093732 equivalent to RU2220960.
WO03/035,624 is the Japanese language equivalent of EP1447402.
Jensen, A.E., et al., Improved nickel-catalyzed cross-coupling reaction conditions between ortho-substituted aryl iodides
onaflates and alkylzinc iodides in solution and in the solid-phase,Tetrahedron, vol. 56: 4197-4201, 2000.
Mathias, L.J., Esterification and alkylation reactions employing isoureas,Synthesis, 561-576, 1979.
Wetterau, J.R., et al., Localization of intracellular triacylglycerol and cholesteryl ester transfer activity in rat tissues,Biochimica et Biophysica Acta, vol. 875: 61-617, 1986.
Wetterau, J.R., et al., Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia,Science, vol. 258: 999-1001, 1992.
WO 99/14196 equivalent to EA 002633B1.
WO 96/040640 equivalent to RU 96111018.
WO 95/32948 equivalent to RU2155754.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted quinoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted quinoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinoline compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4022157

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.